Protective effect of Nigella sativa L. extracts and thymoquinone, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats

Pharmacologyonline

Volumn 1, Issue , 2007, Pages 176-189

  Hosseinzadeh, Hossein ^a   Montahaei, Reza ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lipid peroxidation; Nigella sativa; Renal ischemia reperfusion; Thymoquinone

Indexed keywords

ALCOHOL; LIPID; NIGELLA SATIVA EXTRACT; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL DERIVATIVE; THYMOQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BLACK CUMIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG EFFICACY; EXPERIMENTAL MODEL; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; KIDNEY HOMOGENATE; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY PERFUSION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 34248370219     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17: 299-305.
2. Abdel-Fattah AFM, Matsumoto K, Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol 2000; 400: 89-97.
3. Houghton PJ, Zarka R, De-Las-Heras B, Hoult JR. Fixed oil of Nigella sativa and derived thymoquinone inhibit Eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995; 61: 33-36.
4. Hassan M, El-Dakhakhny M. Effect of some Nigella sativa constituents on chemical carcinogenesis in hamster cheek pouch. J Egypt Soci Pharmacol Exp Ther 1992; 11: 675-677
5. Worthen DR, Ghosheh OA, Crooks PA. The in vitro anti-tumor activity of some crude and purified components of blackseed Nigella sativa L. Anticancer Res 1998; 18: 1527-1532.
6. Daba MH, Abdel-Rahman MS. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol Lett 1998; 95: 23-29.
7. Mansour MA, Ginawi OT, El-Hadiyah T, El-Khatib AS, Al-Shabanah OA, Al-Sawaf HA. Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone. Res Commun Mol Pathol Pharmacol 2001; 110: 239-251.
8. Nagi MN, Alam K, Badary OA, Al-Shabaneh OA, Al-Sawaf HA, Al-Bekairi AM. Thymoquinone protects against carbontetra chloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 1999, 47: 153-159.
9. Mahgoub AA. Thymoquinone protects against experimental colitis in rats. Toxicol Lett 2003; 143: 133-143.
10. Mansour MA, Nagi MN, El-Khatib AS, Al-Bekairi AM. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action. Cell Biochem Funct 2002; 20: 143-151.
11. Dubinsky JM, Kristal BS, Elizondo-Fournier M. An obligate role for oxygen in the early stages of glutamate-induced, delayed neuronal death. J Neurosci 1995; 15: 7071-7078.
12. Patel M, Day, BJ, Crapo JD, Fridovich I, McNamara JO. Requirement for superoxide in excitotoxic cell death. Neuron 1996; 16: 345-355.
13. Cheeseman KH. Mechanisms and effects of lipid peroxidation. Mol Aspects Med 1993; 14: 191-197.
14. Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, Opolon P, Holstege A, Poynard T, Bedossa P. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Path 1997; 50: 401-406.
15. White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neuro Sci. 2000; 179: 1-33.
16. Streck EL, Vieira PS, Wannmacher CMD, Dutra-Filho CS, Wajner M, Wyse ATS. In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab Brain Disease 2003; 18: 147-154.
17. Gilgun-Sherki Y, Rosenbaum Z, Melamed E, Offen D. Antioxidant Therapy in Acute Central Nervous System Injury: Current State. Pharm Rev 2002; 54: 271-284.
18. Unal D, Yeni E, Erel O, Bitiren M, Vural H. Antioxidative effects of exogenous nitric oxide versus antioxidant vitamins on renal ischemia reperfusion injury. Urol Res 2002; 30: 190-194.
19. Fernandez J, Perez-Alvarez JA, Fernandez-lopez JA. Thiobarbituric acid test for monitoring lipid oxidation in meat. Food Chem 1997; 99: 345-353.
20. Uchiama M, Miahara M. Determination of malondealdehyde precursor intissues by thiobarbituric acid test. Anal Biochem 1978; 86: 279-286.
21. Benzie IFF, Strain J. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal Biochem. 1996; 239: 70-76.
22. Benzie IFF, Strain JJ. Ferric reducing / antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999; 299: 15-27.
23. Ellman G. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82: 70-77.
24. Montagna G, Hofer CG, Torres AM. Impairment of cellular redox status and membrane protein activities in kidneys from rats with ischemic acute renal failure. Biochem Biophys Acta 1998; 1407: 99-108.
25. Rhodena E, Teloken C, Lucas M, Rhoden C, Mauri M, Zettler C, Bello-Kleind A, Barros E. Protective effect of allopurinol in the renal ischemia-reperfusion in uninephrectomized rats. General Pharmacol 2002; 35: 189-193.
26. - in post hypoxic injury of renal epithelial cells. Am J Physiol 1992; 263: 251-255.
27. Zager RA, Gmur DJ. Effects of Xanthine oxidase inhibition on ischemic acute renal failure. Acta J Physiol 1989; 257: 953-958.
28. Yoshioka. T, Ichikawa I. Glomerular dysfunction induced by polymorphonulcear leukocyte-derived reactive species. Am J Physiol 1989; 257: 53-59.
29. Paller MS. Renal work, glutathione and susceptibility to free radical-mediated post-ischemic injury. Kidney Int 1988; 33: 843-849.
30. Burns AT, Davies DR, McLaren AJ, Cerundolo L, Morris PJ, Fuggle SV. Apoptosis ischemia/reperfusion injury of human renal albgrafts. Transplant 1998; 66: 872-876.
31. Lee JY, Lott JA, Kauffman EM, Sharma HM. Effect of herbal mixture MAK-4 on organ functions in WHHL rabbits. Biochem Arch 1997; 13: 285-296.
32. Soszynski M, Bartosz G. Decrease in accessible thiols as an index of oxidative damage to membrane proteins. Free Rad Biol Med 1997; 23: 463-469.
33. Abdollahi M, Ranjbar R, Shadnia S, Nikfar S, Rezaie A. Pesticides and oxidative stress: a review. Med Sci Monit 2004; 10: 141-147.
34. Parihar MS, Hemnani T. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J. Bio Sci 2003; 28: 121-128.
35. Badary OA, Nagi MN, Al-Shabanah OA, Al-Shawaf HA, Al-Sohaibani MO, Al-Bekairi AM. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol. 1997; 75: 1356-1361.
36. El-Dakhakhny M, Mady NI, Halim MA. Nigella sativa L. protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneimittelforsch 2000, 50: 832-836.
37. El Daly ES. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharm Bel 1998, 53: 87-95.
38. Türkdogan MK, Agaoglu Z, Yener Z, Sekeroglu R, Akkan HA, Avci ME. The role of antioxidant vitamins (C and E), selenium and Nigella sativa in the prevention of liver fibrosis and cirrhosis in rabbits, new hopes. Dtscch Tierarzt Wschr 2000, 108: 71-73.
39. Al-Gharably NM, Badary OA, Nagi MN, Al-Sawaf HA, Al-Rikabi AC, Al-Bekairi AM. Protective effect of thymoquinone against carbon tetrachloride-induced hepatotoxicity in mice. Res Comm Pharmacol Toxicol 1997, 2: 41-50.
40. El-Abhar HS, Abdallah M, Saleh S. Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia-reperfusion in rats. J Ethnopharmacol 2003, 84: 251-258.
41. Khanna T, Zaidi FA, Dandiya PC. CNS and analgesic studies on Nigella sativa. Fitoterapia 1993, 5: 407-410.
42. Mutabagani A, El-Mahdi SM. A study of the anti-inflammatory activity of Nigella sativa L. and thymoquinone in rats. Saudi Pharmacol J 1997, 5: 110-113.
43. Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol 2001, 76: 45-48.
44. Farail IO, Begum RA. Effect of Nigella sativa (N. sativa L.) and oxidative stress on the survival patternof MCF-7 breast cancer cells. Biomed Sci Instrum 2003, 39: 359-364.